2023-04-01 2024-03-31 false Capium Accounts Production 1.1 13287315 bus:AbridgedAccounts 2023-04-01 2024-03-31 13287315 bus:FRS102 2023-04-01 2024-03-31 13287315 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 13287315 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 13287315 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 13287315 2023-04-01 2024-03-31 13287315 2024-03-31 13287315 bus:RegisteredOffice 2023-04-01 2024-03-31 13287315 core:WithinOneYear 2024-03-31 13287315 core:AfterOneYear 2024-03-31 13287315 bus:Director1 2023-04-01 2024-03-31 13287315 bus:Director1 2024-03-31 13287315 bus:Director1 2022-04-01 2023-03-31 13287315 bus:Director2 2023-04-01 2024-03-31 13287315 bus:Director2 2024-03-31 13287315 bus:Director2 2022-04-01 2023-03-31 13287315 2022-04-01 13287315 bus:LeadAgentIfApplicable 2023-04-01 2024-03-31 13287315 2022-04-01 2023-03-31 13287315 2023-03-31 13287315 core:WithinOneYear 2023-03-31 13287315 core:AfterOneYear 2023-03-31 13287315 bus:EntityAccountantsOrAuditors 2022-04-01 2023-03-31 13287315 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 13287315 core:CostValuation core:Non-currentFinancialInstruments 2023-03-31 13287315 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-03-31 13287315 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-03-31 13287315 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-03-31 13287315 core:Non-currentFinancialInstruments 2024-03-31 13287315 core:Non-currentFinancialInstruments 2023-03-31 13287315 core:ShareCapital 2024-03-31 13287315 core:ShareCapital 2023-03-31 13287315 core:RetainedEarningsAccumulatedLosses 2024-03-31 13287315 core:RetainedEarningsAccumulatedLosses 2023-03-31 13287315 dpl:Item1 2023-04-01 13287315 dpl:Item1 2024-03-31 13287315 dpl:Item1 2022-04-01 13287315 dpl:Item1 2023-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 13287315
England and Wales

 

 

 

BIOCUBE MATRICS LIMITED


Abridged Accounts
 


Period of accounts

Start date: 01 April 2023

End date: 31 March 2024
 
 
Notes
 
2024
£
  2023
£
Current assets      
Debtors 129,316    131,004 
Cash at bank and in hand 5,850    1,288 
135,166    132,292 
Creditors: amount falling due within one year (145,412)   (214,197)
Net current assets (10,246)   (81,905)
 
Total assets less current liabilities (10,246)   (81,905)
Provisions for liabilities (143)   (535)
Net assets (10,389)   (82,440)
 

Capital and reserves
     
Called up share capital 1,000    1,000 
Profit and loss account (11,389)   (83,440)
Shareholders' funds (10,389)   (82,440)
 


For the year ended 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the profit and loss account has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the board of directors on 04 July 2024 and were signed on its behalf by:


-------------------------------
Yaver Unnisa
Director
1
General Information
Biocube Matrics Limited is a private company, limited by shares, registered in England and Wales, registration number 13287315, registration address 213 Kingsbury Road, Jubilee Business Centre, London, NW9 8AQ.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Going concern basis
The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rate of exchange ruling at the balance sheet date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All foreign exchange differences are included to the profit and loss account.
2.

Average number of employees

Average number of employees during the year was 3 (2023 : 3).
3.

Related party transactions

Amount due to Bicoube Technologies Inc of £28,571.18 (last year : £ 175,826.31 ) and amount due from Kubberlaxmi Limited of £127,700.00 (last year: £ 125,000 ).

2